SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

HPV Vaccine enhanced with an adjuvant

By 1 Comment

VIHC Vaccine Injury Help Center Posted on June 6, 2011 by Vaccine Injury Lawyer According to an article for Medical News Today, “The immune response against the virus that causes cervical cancer is stronger and sustained following vaccination with GlaxoSmithKline’s (GSK) candidate HPV vaccine formulated with the innovative AS04 adjuvant compared to using the same […]




[Continue reading...]

How safe is Gardasil? ( extracted from the Immunise Australia literature)

By Leave a Comment

Vaccine Information S.A It is a frustrating time when our young girls and women are being lined up and jabbed with a vaccine that has the potential to affect their future fertility – HPV (Gardasil) vaccine – and that may be the least of the problems. Anyone with a HPV infection (and they are common), […]




[Continue reading...]

HPV Vaccine Safety and Efficacy: Answers Needed from Government Health Ministers

By Leave a Comment

        By Judy Wilyman  MSc The One Click Group June 4, 2011 In Australia, as in some other countries, the HPV vaccine – Gardasil® – is being promoted to adolescents, woman and now boys, as a vaccine to prevent cervical cancer. Government health departments are not addressing the concerns of parents. There are […]




[Continue reading...]

UK Government Documents on Aluminium in Vaccines

By Leave a Comment

Age of Autism The shocking truth about aluminium (aluminum) in vaccines from UK government documents John Heptonstall In September 2010 the Medicines and Healthcare products Regulatory Agency, MHRA, which is the government agency responsible for regulating medicines and medical devices in the UK, reported that there was a risk of aluminium exposure caused by calcium […]




[Continue reading...]

Aluminum Toxicity: A misdiagnosed epidemic (Part 1)

By Leave a Comment

ProLiberty.com From the December 2007 Idaho Observer: By Ingri Cassel Aluminum is the third most abundant element (8 percent) in the Earth’s crust, exceeded by oxygen (47 percent) and silicon (28 percent). Because of its strong affinity to oxygen, aluminum never occurs as a metal in nature but is found only in the form of […]




[Continue reading...]

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.

By

Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Source Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Abstract Aluminium adjuvants, typically referred to as ‘alum’, are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by […]




[Continue reading...]

A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome

By

Christopher Exley, Louise Swarbrick, Rhomain K. Gherardi, and Francois-Jérôme Arthier Summary:  Macrophagic myofasciitis and chronic fatigue syndrome are severely disabling conditions which may be caused by  adverse reactions to aluminium-containing adjuvants in vaccines. While a little is known of disease aetiology both conditions are characterised by an aberrant immune response, have a number of prominent […]




[Continue reading...]

The immunobiology of aluminium adjuvants: how do they really work?

By

Christopher Exley, Peter Siesjö, and Håkan Eriksson  ABSTRACT:  Aluminium adjuvants potentiate the immune response, thereby ensuring the potency and efficacy of typically sparingly available antigen. Their concomitant critical mportance in mass vaccination programmes may have prompted recent intense interest in understanding how they work and their safety. Progress in these areas is stymied, however, by […]




[Continue reading...]

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By Leave a Comment

McKeage K, Romanowski B; Drugs 71 (4), 465-8 (Mar 2011) The AS04-adjuvanted human papillomavirus (HPV) 16/18 vaccine (Cervarix®) is a noninfectious recombinant vaccine produced using purified virus-like particles (VLPs) that induce a strong immunogenic response eliciting high levels of anti-L1 VLP antibodies that persist at levels markedly greater than those observed with natural infection. The […]




[Continue reading...]

Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction.

By

J Inorg Biochem. 2009 Nov;103(11):1571-8. Epub 2009 Aug 20. Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ. Abstract Macrophagic myofasciitis (MMF) is an emerging condition, characterized by specific muscle lesions assessing long-term persistence of aluminum hydroxide within macrophages at the site of previous immunization. Affected […]




[Continue reading...]

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle

By

Macrophagic myofasciitis (MMF) is an emerging condition of unknown cause, detected in patients with diffuse arthromyalgias and fatigue, and characterized by muscle infiltration by granular periodic acid-Schiff’s reagent-positive macrophages and lymphocytes. Itrracytoplasmic inclusions have been observed in macrophages of some patients….. We conclude that the MMF lesion is secondary to intramuscular injection of aluminum hydroxide-containing […]




[Continue reading...]

Aluminum adjuvant linked to Gulf War Illness induces motor neuron death in mice

By

Michael S. Petrik, Margaret C. Wong, Rena C. Tabata, Robert F. Garry and Christopher A. Shaw Abstract Gulf War illness (GWI) affects a significant percentage of veterans of the 1991 conflict, but its origin remains unknown. Associated with some cases of GWI are increased incidences of amyotrophic lateral sclerosis and other neurological disorders. Whereas many […]




[Continue reading...]

New-Age Vaccine Adjuvants: Friend or Foe?

By

By:  Nikolai Petrovsky, Susanne Heinzel, Yoshikazu Honda, and A. Bruce Lyons A major unsolved challenge in development is how to achieve a potent adjuvant effect while avoiding reactogenicity or toxicity. Older vaccines made from live or killed whole organisms were effective, but suffered from high reactogenicity. As vaccine manufacturers developed safer, less reactogenic subunit vaccines, […]




[Continue reading...]

Aluminum Hydroxide Injections Lead to Motor Deficits and Motor Neuron Degeneration

By

Authors:  Christopher Shaw/Michael Petrik 10 Feb 2010 Abstract:  Gulf War Syndrome is a multi-system disorder afflicting many veterans of Western armies in the 1990–1991 Gulf War. A number of those afflicted may show neurological deficits including various cognitive dysfunctions and motor neuron disease, the latter expression virtually indistinguishable from classical amyotrophic lateral sclerosis (ALS) except […]




[Continue reading...]

Synoptic Overview: Issues in Immunization Theory and Practice

By

Prepared by:  Raymond Obamsowin November 2009 IMMUNIZATION THEORY ISSUES: Theory: Vaccination is the injection of antigenic material, such as pathogen derived foreigh proteins and toxic adjuvants into the body, to initiate a “learned” immune system response in order to prevent particular diseases. Memory T cells (cell-mediated immunity) and Memory B cells (humoral-mediated immunity) learn to […]




[Continue reading...]

News

Videos

Contact